News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
707,872 Results
Type
Article (40426)
Company Profile (275)
Press Release (667170)
Multimedia
Podcasts (62)
Webinars (14)
Section
Business (205242)
Career Advice (2024)
Deals (35576)
Drug Delivery (97)
Drug Development (81352)
Employer Resources (172)
FDA (16280)
Job Trends (14943)
News (346831)
Policy (32722)
Tag
Academia (2576)
Accelerated approval (9)
Adcomms (22)
Allergies (96)
Alliances (49937)
ALS (108)
Alzheimer's disease (1449)
Antibody-drug conjugate (ADC) (154)
Approvals (16276)
Artificial intelligence (310)
Autoimmune disease (29)
Automation (18)
Bankruptcy (364)
Best Places to Work (11659)
BIOSECURE Act (20)
Biosimilars (122)
Biotechnology (191)
Bladder cancer (94)
Brain cancer (33)
Breast cancer (365)
Cancer (2866)
Cardiovascular disease (212)
Career advice (1693)
Career pathing (30)
CAR-T (188)
CDC (30)
Cell therapy (504)
Cervical cancer (22)
Clinical research (66985)
Collaboration (1024)
Company closure (3)
Compensation (686)
Complete response letters (22)
COVID-19 (2640)
CRISPR (57)
C-suite (327)
Cystic fibrosis (113)
Data (2994)
Decentralized trials (2)
Denatured (23)
Depression (62)
Diabetes (347)
Diagnostics (6445)
Digital health (23)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (138)
Drug pricing (123)
Drug shortages (28)
Duchenne muscular dystrophy (124)
Earnings (87577)
Editorial (40)
Employer branding (21)
Employer resources (148)
Events (114267)
Executive appointments (853)
FDA (17928)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (937)
Gene editing (131)
Generative AI (22)
Gene therapy (374)
GLP-1 (784)
Government (4517)
Grass and pollen (4)
Guidances (181)
Healthcare (18864)
Huntington's disease (31)
IgA nephropathy (39)
Immunology and inflammation (151)
Immuno-oncology (8)
Indications (39)
Infectious disease (2813)
Inflammatory bowel disease (153)
Inflation Reduction Act (12)
Influenza (63)
Intellectual property (119)
Interviews (312)
IPO (16627)
IRA (46)
Job creations (3671)
Job search strategy (1436)
Kidney cancer (13)
Labor market (52)
Layoffs (498)
Leadership (18)
Legal (7965)
Liver cancer (79)
Lung cancer (399)
Lymphoma (208)
Machine learning (11)
Management (58)
Manufacturing (385)
MASH (90)
Medical device (13476)
Medtech (13481)
Mergers & acquisitions (19662)
Metabolic disorders (849)
Multiple sclerosis (97)
NASH (16)
Neurodegenerative disease (115)
Neuropsychiatric disorders (33)
Neuroscience (2128)
NextGen: Class of 2025 (6555)
Non-profit (4499)
Now hiring (47)
Obesity (427)
Opinion (221)
Ovarian cancer (101)
Pain (106)
Pancreatic cancer (122)
Parkinson's disease (186)
Partnered (22)
Patents (298)
Patient recruitment (163)
Peanut (51)
People (58023)
Pharmaceutical (67)
Pharmacy benefit managers (21)
Phase I (20890)
Phase II (29512)
Phase III (21954)
Pipeline (1631)
Policy (201)
Postmarket research (2564)
Preclinical (8904)
Press Release (64)
Prostate cancer (139)
Psychedelics (36)
Radiopharmaceuticals (253)
Rare diseases (459)
Real estate (5968)
Recruiting (66)
Regulatory (22700)
Reports (50)
Research institute (2334)
Resumes & cover letters (351)
Rett syndrome (9)
RNA editing (9)
RSV (49)
Schizophrenia (86)
Series A (161)
Series B (109)
Service/supplier (13)
Sickle cell disease (60)
Special edition (18)
Spinal muscular atrophy (148)
Sponsored (32)
Startups (3644)
State (2)
Stomach cancer (14)
Supply chain (76)
Tariffs (57)
The Weekly (37)
Vaccines (782)
Venture capital (55)
Weight loss (257)
Women's health (47)
Worklife (16)
Date
Today (66)
Last 7 days (370)
Last 30 days (1879)
Last 365 days (31355)
2025 (16797)
2024 (35337)
2023 (40185)
2022 (51295)
2021 (55841)
2020 (54167)
2019 (46646)
2018 (35134)
2017 (32235)
2016 (31633)
2015 (37715)
2014 (31460)
2013 (26503)
2012 (28779)
2011 (29428)
2010 (27529)
Location
Africa (723)
Alabama (61)
Alaska (7)
Arizona (243)
Arkansas (13)
Asia (38430)
Australia (6280)
California (7457)
Canada (2356)
China (671)
Colorado (322)
Connecticut (318)
Delaware (192)
Europe (82669)
Florida (1115)
Georgia (247)
Hawaii (1)
Idaho (60)
Illinois (639)
India (27)
Indiana (362)
Iowa (16)
Japan (227)
Kansas (109)
Kentucky (29)
Louisiana (14)
Maine (64)
Maryland (1021)
Massachusetts (5539)
Michigan (246)
Minnesota (450)
Mississippi (3)
Missouri (89)
Montana (28)
Nebraska (25)
Nevada (80)
New Hampshire (67)
New Jersey (2072)
New Mexico (28)
New York (2084)
North Carolina (1079)
North Dakota (8)
Northern California (3279)
Ohio (237)
Oklahoma (16)
Oregon (35)
Pennsylvania (1613)
Puerto Rico (17)
Rhode Island (36)
South America (1101)
South Carolina (34)
South Dakota (1)
Southern California (2790)
Tennessee (126)
Texas (1126)
United States (27599)
Utah (219)
Virginia (185)
Washington D.C. (73)
Washington State (634)
West Virginia (4)
Wisconsin (66)
707,872 Results for "upstream biosciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Upstream Bio Appoints Stacy Price as Chief Technology Officer
May 20, 2025
·
6 min read
Press Releases
Upstream Bio Announces First Patient Dosed in Phase 2 Clinical Trial of Verekitug in Chronic Obstructive Pulmonary Disease (COPD)
July 9, 2025
·
10 min read
Press Releases
Upstream Bio Reports First Quarter 2025 Financial Results and Accelerates Guidance on All Clinical Programs
May 7, 2025
·
11 min read
IPO
Upstream Raises $255M IPO for Inflammatory Drugs; CAMP4 Nets $75M for RNA Work
Two biotechs set out for the public markets this week, with Upstream Bio raising $255 million for its inflammatory disease work, while CAMP4 Therapeutics picked up $75 million to develop RNA-targeting drugs.
October 11, 2024
·
1 min read
·
Annalee Armstrong
Press Releases
Upstream Bio to Present at Upcoming March Investor Conferences
February 25, 2025
·
1 min read
Press Releases
Upstream Bio to Present Mechanistic Insights into Verekitug’s Enhanced Potency via TSLP Receptor Targeting at European Academy of Allergy and Clinical Immunology (EAACI) Congress 2025
June 5, 2025
·
6 min read
Press Releases
Upstream Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
March 12, 2025
·
10 min read
Press Releases
Upstream Bioprocessing Market Size to Reach $105.46 Bn by 2034
February 17, 2025
·
1 min read
Press Releases
Upstream Bio Appoints Allison Ambrose as General Counsel
December 17, 2024
·
5 min read
Business
Upstream Bio Announces Appointment of Rand Sutherland as CEO and Additions to Leadership Team
Upstream Bio, a clinical-stage biotech company advancing verekitug for respiratory disorders, announced strategic leadership changes including the appointment of Rand Sutherland, MD, as Chief Executive Officer.
April 2, 2024
·
4 min read
1 of 70,788
Next
